Predicted Trait | |
Reported Trait | Other metabolic disorders (time-to-event) |
Mapped Trait(s) | metabolic disease (EFO_0000589) |
Additional Trait Information | https://biobankengine.stanford.edu/RIVAS_HG19/snpnet/HC708 |
Score Construction | |
PGS Name | GBE_HC708 |
Development Method | |
Name | snpnet |
Parameters | NR |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 2 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000244 |
Citation (link to publication) | Tanigawa Y et al. PLoS Genet (2022) |
Ancestry Distribution | |
Score Development/Training | European: 100% 269,704 individuals (100%) |
PGS Evaluation | European: 50% African: 25% South Asian: 25% 4 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | [
|
European | UKB | — | — | — | white British ancestry | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM009088 | PSS004610| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other metabolic disorders | — | AUROC: 0.77406 [0.68678, 0.86135] | R²: 0.06649 Incremental AUROC (full-covars): -0.00199 PGS R2 (no covariates): 0.00603 PGS AUROC (no covariates): 0.44259 [0.3516, 0.53358] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009089 | PSS004611| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other metabolic disorders | — | AUROC: 0.70958 [0.62744, 0.79171] | R²: 0.04504 Incremental AUROC (full-covars): 0.02495 PGS R2 (no covariates): 0.01479 PGS AUROC (no covariates): 0.54987 [0.46099, 0.63876] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009090 | PSS004612| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other metabolic disorders | — | AUROC: 0.64684 [0.54842, 0.74526] | R²: 0.02913 Incremental AUROC (full-covars): -0.00029 PGS R2 (no covariates): 0.00067 PGS AUROC (no covariates): 0.52382 [0.42834, 0.61931] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009091 | PSS004613| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other metabolic disorders | — | AUROC: 0.60186 [0.54294, 0.66079] | R²: 0.02952 Incremental AUROC (full-covars): 0.09428 PGS R2 (no covariates): 0.05151 PGS AUROC (no covariates): 0.62356 [0.56795, 0.67918] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS004612 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004613 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004610 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004611 | — | — | [
|
— | European | non-white British ancestry | UKB | — |